CMA welcomes federal action plan to secure personal protective equipment for health care workers
OTTAWA, March 20, 2020 /CNW/ - The Canadian Medical Association (CMA) welcomes the Government of Canada's decision to mobilize businesses and manufacturers to urgently produce personal protective equipment (PPE) and other critical supplies needed to combat COVID-19.
The action plan, and the response from industry and the innovation sector, speak to Canada's ingenuity and agility to protect health care workers and ensure Canadians receive the best possible care. Securing an adequate supply of PPE, diagnostic and testing products, and disease tracking technology, are critical components of an effective response to the pandemic.
Earlier this week, the CMA outlined key priorities to respond to COVID-19. Ensuring an adequate supply of PPE was outlined as a priority recommendation, given concerns raised by health professionals across the country.
The CMA continues to work closely with all key stakeholders, including the federal government and health care organizations, to optimize a coordinated response to this pandemic.
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...
